COO
Price
$93.27
Change
+$1.23 (+1.34%)
Updated
Jan 17 closing price
Capitalization
19.72B
40 days until earnings call
PODD
Price
$275.81
Change
+$2.95 (+1.08%)
Updated
Jan 17 closing price
Capitalization
11.75B
33 days until earnings call
Ad is loading...

COO vs PODD

Header iconCOO vs PODD Comparison
Open Charts COO vs PODDBanner chart's image
Cooper Companies (The)
Price$93.27
Change+$1.23 (+1.34%)
Volume$1.95M
Capitalization19.72B
Insulet
Price$275.81
Change+$2.95 (+1.08%)
Volume$554.11K
Capitalization11.75B
COO vs PODD Comparison Chart
Loading...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COO vs. PODD commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a Hold and PODD is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (COO: $93.27 vs. PODD: $275.81)
Brand notoriety: COO and PODD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: COO: 132% vs. PODD: 100%
Market capitalization -- COO: $19.72B vs. PODD: $11.75B
COO [@Medical Specialties] is valued at $19.72B. PODD’s [@Medical Specialties] market capitalization is $11.75B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COO’s FA Score shows that 0 FA rating(s) are green whilePODD’s FA Score has 2 green FA rating(s).

  • COO’s FA Score: 0 green, 5 red.
  • PODD’s FA Score: 2 green, 3 red.
According to our system of comparison, PODD is a better buy in the long-term than COO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COO’s TA Score shows that 4 TA indicator(s) are bullish while PODD’s TA Score has 4 bullish TA indicator(s).

  • COO’s TA Score: 4 bullish, 3 bearish.
  • PODD’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, PODD is a better buy in the short-term than COO.

Price Growth

COO (@Medical Specialties) experienced а +3.28% price change this week, while PODD (@Medical Specialties) price change was +1.46% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

COO is expected to report earnings on Feb 27, 2025.

PODD is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COO($19.7B) has a higher market cap than PODD($11.8B). COO has higher P/E ratio than PODD: COO (68.09) vs PODD (57.17). PODD YTD gains are higher at: 5.646 vs. COO (1.458). COO has higher annual earnings (EBITDA): 895M vs. PODD (324M). PODD has more cash in the bank: 704M vs. COO (135M). PODD has less debt than COO: PODD (1.42B) vs COO (2.77B). COO has higher revenues than PODD: COO (3.67B) vs PODD (1.7B).
COOPODDCOO / PODD
Capitalization19.7B11.8B167%
EBITDA895M324M276%
Gain YTD1.4585.64626%
P/E Ratio68.0957.17119%
Revenue3.67B1.7B216%
Total Cash135M704M19%
Total Debt2.77B1.42B196%
FUNDAMENTALS RATINGS
COO vs PODD: Fundamental Ratings
COO
PODD
OUTLOOK RATING
1..100
6610
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
7053
SMR RATING
1..100
8321
PRICE GROWTH RATING
1..100
5921
P/E GROWTH RATING
1..100
8696
SEASONALITY SCORE
1..100
3650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PODD's Valuation (84) in the Medical Specialties industry is in the same range as COO (90). This means that PODD’s stock grew similarly to COO’s over the last 12 months.

PODD's Profit vs Risk Rating (53) in the Medical Specialties industry is in the same range as COO (70). This means that PODD’s stock grew similarly to COO’s over the last 12 months.

PODD's SMR Rating (21) in the Medical Specialties industry is somewhat better than the same rating for COO (83). This means that PODD’s stock grew somewhat faster than COO’s over the last 12 months.

PODD's Price Growth Rating (21) in the Medical Specialties industry is somewhat better than the same rating for COO (59). This means that PODD’s stock grew somewhat faster than COO’s over the last 12 months.

COO's P/E Growth Rating (86) in the Medical Specialties industry is in the same range as PODD (96). This means that COO’s stock grew similarly to PODD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COOPODD
RSI
ODDS (%)
Bullish Trend 11 days ago
72%
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
57%
Bearish Trend 11 days ago
74%
Momentum
ODDS (%)
Bearish Trend 11 days ago
54%
Bullish Trend 11 days ago
79%
MACD
ODDS (%)
Bullish Trend 11 days ago
68%
Bullish Trend 11 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
57%
Bullish Trend 11 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
59%
Bullish Trend 11 days ago
73%
Advances
ODDS (%)
Bullish Trend 13 days ago
62%
Bullish Trend 13 days ago
75%
Declines
ODDS (%)
Bearish Trend 11 days ago
56%
Bearish Trend 17 days ago
69%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
49%
N/A
View a ticker or compare two or three
Ad is loading...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
FTT.X2.6359960.251701
+10.56%
FTX Token cryptocurrency
FLUX.X0.6123020.037932
+6.60%
Flux cryptocurrency
IMSI51.150.12
+0.23%
Invesco Municipal Strategic Income ETF
IBTK19.19-0.02
-0.10%
iShares iBonds Dec 2030 Term Trsry ETF
UGA66.14-0.39
-0.59%
United States Gasoline

COO and

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been loosely correlated with ALC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then ALC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
+1.34%
ALC - COO
52%
Loosely correlated
+0.27%
WAT - COO
37%
Loosely correlated
-0.35%
A - COO
36%
Loosely correlated
+1.82%
BRKR - COO
36%
Loosely correlated
-3.61%
AXGN - COO
35%
Loosely correlated
-1.84%
More

PODD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PODD has been loosely correlated with XRAY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PODD jumps, then XRAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PODD
1D Price
Change %
PODD100%
+1.08%
XRAY - PODD
34%
Loosely correlated
+1.79%
ISRG - PODD
34%
Loosely correlated
+1.47%
MMSI - PODD
32%
Poorly correlated
+0.81%
COO - PODD
32%
Poorly correlated
+1.34%
NVST - PODD
32%
Poorly correlated
+3.34%
More